Form 4: Nephros Inc. Director Joseph Michael Harris Reports Stock Option Grant
SEC Form 4 Filing
Director Joseph Michael Harris reports the acquisition of stock options in Nephros Inc. related to his board service.
Summary
- Joseph Michael Harris, a director of Nephros Inc., filed a Form 4 disclosing changes in his beneficial ownership of the company's securities.
- The report details the grant of stock options to Harris for his service on the Company's Board of Directors for 2024.
- Specifically, Harris was granted options to purchase 7,050 shares of common stock at an exercise price of $1.47.
- These options vest in three equal installments of 2,350 shares on January 1, 2025, January 1, 2026, and January 1, 2027.
- Following the reported transaction, Harris directly owns 17,693 shares of Nephros Inc. common stock.
- Harris also holds options to purchase an additional 27,518 shares at exercise prices of $1.07, $1.25 and $2.14.
Sentiment
Score: 6
Explanation: The document is neutral, simply reporting a stock option grant. It's a standard practice, so neither particularly positive nor negative.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule incentivizes continued service on the board.
Industry Context
Stock option grants to directors are a common practice to align their interests with those of shareholders and incentivize their service.
Stakeholder Impact
- The stock option grant could have a minor positive impact on shareholder sentiment as it aligns director interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/05/2023 | Vesting date for 2,360 shares of stock option with exercise price of $1.07. |
| 01/05/2024 | Vesting date for 2,360 shares of stock option with exercise price of $1.07. |
| 05/14/2024 | Vesting date for 2,441 shares of stock option with exercise price of $2.14. |
| 01/01/2025 | Date of earliest transaction and vesting date for 2,350 shares of stock option with exercise price of $1.47 and vesting date for 2,360 shares of stock option with exercise price of $1.07. |
| 01/01/2025 | Date of earliest transaction and vesting date for 2,350 shares of stock option with exercise price of $1.47. |
| 05/14/2025 | Vesting date for 2,441 shares of stock option with exercise price of $2.14. |
| 01/01/2026 | Vesting date for 2,350 shares of stock option with exercise price of $1.47. |
| 05/14/2026 | Vesting date for 2,441 shares of stock option with exercise price of $2.14. |
| 01/01/2027 | Vesting date for 2,350 shares of stock option with exercise price of $1.47. |
| 09/06/2032 | Expiration date for stock option with exercise price of $1.25. |
| 01/05/2033 | Expiration date for stock option with exercise price of $1.07. |
| 05/14/2034 | Expiration date for stock option with exercise price of $2.14. |
| 01/01/2035 | Expiration date for stock option with exercise price of $1.47. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.